Obesity cardiomyopathy could contribute to sudden cardiac death: a Japanese epidemiological morphological study

Ryo Kaimori1,2, Haruto Nishida3, Mari Tamura4

  • 1Department of Forensic Medicine, Faculty of Medicine, Oita University, 1-1 Idaigaoka, Hasama-machi, Yufu, Oita, 879-5593, Japan. kaimori@oita-u.ac.jp.

PubMed

Insights

Obesity cardiomyopathy (OCM) is present in Japan, with 6.5% of autopsy cases showing cardiac hypertrophy. This condition, linked to obesity, is associated with sudden cardiac death (SCD), highlighting the need for OCM recognition.

Area of Science:

  • Cardiovascular Pathology
  • Obesity Research
  • Autopsy Studies

Background:

  • Obesity cardiomyopathy (OCM) is a cardiac condition associated with obesity.
  • Its existence and pathological characteristics in Japan remain unclear.

Purpose of the Study:

  • To determine the prevalence and pathological features of OCM in Japan.
  • To compare OCM cases with obesity without cardiac hypertrophy (OB) and normal controls.

Main Methods:

  • Retrospective autopsy study of 294 cases.
  • OCM defined by cardiac hypertrophy (men ≥ 400g, women ≥ 320g) in obese individuals (BMI ≥ 25 kg/m²).
  • Macroscopic (heart weight, adipose tissue) and microscopic (fibrosis, cardiomyocyte diameter) analyses were performed.

Main Results:

  • 19 cases (6.5%) of OCM were identified.
  • OCM hearts were significantly heavier than OB hearts (median 435g vs. 360g).
  • OCM hearts showed a "globoid" appearance, thickened right ventricular outflow tract, and focal left ventricular fibrosis. Approximately 50% of OCM cases resulted in sudden cardiac death (SCD).

Conclusions:

  • OCM prevalence in Japan may be higher than previously thought.
  • OCM presents specific pathological findings.
  • OCM is strongly associated with SCD, necessitating its recognition and diagnosis.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
1
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
3
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
3
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
1